NCT07113340Active, not recruiting
Carina™ Surgical Platform for Minimal Radical Gastrectomy
Carina™ Platform - A Single-arm Study for Gastrectomy
Source: ClinicalTrials.gov · Last updated 8 Aug 2025
Brief summary (registry, in English)
To evaluate the safety and effectiveness of the laparoscopic surgical system（Carina™ Surgical Platform, developed by Ronovo Surgical, Inc) for use in gastrectomy.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 14 Jun 2025
- Start date
- 1 May 2025
- Primary completion date
- 1 Oct 2025
- Lead sponsor
- The Affiliated Hospital of Qingdao University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07113340
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 1 May 2025 to the primary completion date, 1 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients currently participating in other drug or medical device clinical trials
Other illness
- Patients with severe cardiovascular diseases who cannot tolerate laparoscopic surgery
- Patients with severe respiratory diseases who cannot tolerate laparoscopic surgery
- Patients with severe coagulation disorders who cannot tolerate laparoscopic surgery
- Patients with a history of abdominal or pelvic surgery, radiotherapy, or chemotherapy who are not suitable for laparoscopic surgery
Other
- BMI \< 18.5 kg/m² or BMI ≥ 30 kg/m²
- Pregnant or breastfeeding women
- Patients deemed unsuitable for participation in this study by the investigator
Who the study is looking for
- Age between 18 and 80 years, any gender
- Patients with gastric cancer planned to undergo laparoscopic surgery assisted by the laparoscopic surgical system
- Agree to participate in this study and voluntarily sign the informed consent form
- Willing to cooperate with study follow-up and related examinations
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Affiliated Hospital of Qingdao University Coordinator of this site? Confirm its status | Qingdao | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.